Recently, a multinational cohort study revealed that heterozygous carriage of the Pi*Z variant (“Pi*MZ” genotype) is a strong disease modifier in metabolic liver disease (i.e., alcoholic and non-alcoholic fatty liver disease) [16,17,18]. The gene discussed is SERPINA1; the disease is alcoholic fatty liver disease.